Drug intelligence / Profile preview

PHARMAPATCH

Development stage
Unknown
Lead developer
PharmaTher
Modality
Small Molecules
Administration
Transdermal
01

Overview

PHARMAPATCH is a transdermal ketamine delivery system being developed by PharmaTher Holdings Ltd. for the management of acute postoperative and chronic pain. The patch utilizes proprietary microneedle technology to provide controlled, sustained release of ketamine, an NMDA receptor antagonist, aiming to maintain constant therapeutic plasma levels for over 24 hours while minimizing side effects associated with peak-and-trough concentrations. Developed via the FDA 505(b)(2) regulatory pathway, PHARMAPATCH is designed as a non-opioid alternative for analgesia and includes anti-tampering and anti-abuse features. Beyond pain management, the company is exploring its potential in mental health indications such as treatment-resistant depression, suicidality, and PTSD.

Brand names
PHARMAPATCH
Other names
ketamine transdermal patchtransdermal patch (ketamine)
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on PHARMAPATCH.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHARMAPATCH.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call